Cargando…
Part 5: Myelodysplastic syndromes—Treatment of high-risk disease
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098179/ https://www.ncbi.nlm.nih.gov/pubmed/30128439 http://dx.doi.org/10.1016/j.htct.2018.05.013 |
| _version_ | 1783348421048926208 |
|---|---|
| author | Magalhães, Silvia Maria Meira Chauffaille, Maria de Lourdes Lopes Ferrari Velloso, Elvira Deolinda Rodrigues Pereira Buzzini, Renata Bernardo, Wanderley Marques |
| author_facet | Magalhães, Silvia Maria Meira Chauffaille, Maria de Lourdes Lopes Ferrari Velloso, Elvira Deolinda Rodrigues Pereira Buzzini, Renata Bernardo, Wanderley Marques |
| author_sort | Magalhães, Silvia Maria Meira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6098179 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60981792018-08-20 Part 5: Myelodysplastic syndromes—Treatment of high-risk disease Magalhães, Silvia Maria Meira Chauffaille, Maria de Lourdes Lopes Ferrari Velloso, Elvira Deolinda Rodrigues Pereira Buzzini, Renata Bernardo, Wanderley Marques Hematol Transfus Cell Ther Guideline Sociedade Brasileira de Hematologia e Hemoterapia 2018 2018-07-27 /pmc/articles/PMC6098179/ /pubmed/30128439 http://dx.doi.org/10.1016/j.htct.2018.05.013 Text en © 2018 Published by Elsevier Editora Ltda. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Guideline Magalhães, Silvia Maria Meira Chauffaille, Maria de Lourdes Lopes Ferrari Velloso, Elvira Deolinda Rodrigues Pereira Buzzini, Renata Bernardo, Wanderley Marques Part 5: Myelodysplastic syndromes—Treatment of high-risk disease |
| title | Part 5: Myelodysplastic syndromes—Treatment of high-risk disease |
| title_full | Part 5: Myelodysplastic syndromes—Treatment of high-risk disease |
| title_fullStr | Part 5: Myelodysplastic syndromes—Treatment of high-risk disease |
| title_full_unstemmed | Part 5: Myelodysplastic syndromes—Treatment of high-risk disease |
| title_short | Part 5: Myelodysplastic syndromes—Treatment of high-risk disease |
| title_sort | part 5: myelodysplastic syndromes—treatment of high-risk disease |
| topic | Guideline |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098179/ https://www.ncbi.nlm.nih.gov/pubmed/30128439 http://dx.doi.org/10.1016/j.htct.2018.05.013 |
| work_keys_str_mv | AT magalhaessilviamariameira part5myelodysplasticsyndromestreatmentofhighriskdisease AT chauffaillemariadelourdeslopesferrari part5myelodysplasticsyndromestreatmentofhighriskdisease AT vellosoelviradeolindarodriguespereira part5myelodysplasticsyndromestreatmentofhighriskdisease AT buzzinirenata part5myelodysplasticsyndromestreatmentofhighriskdisease AT bernardowanderleymarques part5myelodysplasticsyndromestreatmentofhighriskdisease |